1. Current development in regulation of similar biotherapeutic products in Brazil;Castanheira;Biologicals,2011
2. Kirchlechner T. Current regulations of biosimilars in the Latin American region. Paper presented at: 3rd Annual Drug Information Association (DIA) Latin American Regulatory Conference, Panama City, Panama, April 12–15, 2011.
3. Expert Committee on Biological Standardization,2009
4. Pinto V. Biologics and biosimilars in Brazil: regulatory outlook and pharmacoeconomic challenges. In: ISPOR 3rd Latin America Conference. Mexico City, Mexico, September 10, 2011.
5. Federal Drug Administration. Scientific Considerations in Demonstrating Biosimilarity to a Reference Product – Draft Guidance. Rockville, MD: U.S. Department of Health and Human Services, February 2012.